Overview
Ryuji Ohashi practices in Tokyo, Japan. Mr. Ohashi is highly rated in 9 conditions, according to our data. His top areas of expertise are Glomerulonephritis, Membranoproliferative Glomerulonephritis, Nephrosclerosis, Splenectomy, and Kidney Transplant.
His clinical research consists of co-authoring 120 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Breast CancerMr. Ohashi isAdvanced. Learn about Breast Cancer.
- Fanconi Bickel SyndromeMr. Ohashi isAdvanced. Learn about Fanconi Bickel Syndrome.
- Fanconi SyndromeMr. Ohashi isAdvanced. Learn about Fanconi Syndrome.
- Focal Segmental Glomerulosclerosis
- GlomerulonephritisMr. Ohashi isAdvanced. Learn about Glomerulonephritis.
- Interstitial NephritisMr. Ohashi isAdvanced. Learn about Interstitial Nephritis.
- Experienced
- Acute Tubular NecrosisMr. Ohashi isExperienced. Learn about Acute Tubular Necrosis.
- Adenoid Cystic CarcinomaMr. Ohashi isExperienced. Learn about Adenoid Cystic Carcinoma.
- Adult Soft Tissue SarcomaMr. Ohashi isExperienced. Learn about Adult Soft Tissue Sarcoma.
- AminoaciduriaMr. Ohashi isExperienced. Learn about Aminoaciduria.
- ArthritisMr. Ohashi isExperienced. Learn about Arthritis.
- Autoimmune Hemolytic AnemiaMr. Ohashi isExperienced. Learn about Autoimmune Hemolytic Anemia.